NANOBIOTIX to Participate in Investor Conferences in March

Rhea-AI Summary

NANOBIOTIX (NASDAQ: NBTX) announced management will attend multiple investor conferences in March 2026, including TD Cowen Health Care, UBS Biotech Summit Miami, Jefferies Biotech on the Beach, and Leerink's Global Healthcare Conference.

Presenters Laurent Levy, CEO, and Bart van Rhijn, CFO & Business Officer, will host scheduled fireside chats on March 4 and March 11, 2026, with locations in Boston and Miami Beach and specific times listed for investor access.

PARIS and CAMBRIDGE, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that Company management will participate in these upcoming conferences in March:

TD Cowen's Health Care Conference
Date: Wednesday, March 4, 2026
Location: Boston, MA
Time of the fireside chat: 11:10am ET / 5:10pm CET
Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix

UBS Biotech Summit Miami
Date: Monday, March 9, 2026
Location: Miami Beach, FL

Jefferies Biotech on the Beach Summit
Date: Tuesday, March 10, 2026
Location: Miami Beach, FL

Leerink's Global Healthcare Conference
Date: Wednesday, March 11, 2026
Location: Miami Beach, FL
Time of the fireside chat: 2:20pm EDT / 7:20pm CET
Presenters: Laurent Levy, Chief Executive Officer of Nanobiotix and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix

About NANOBIOTIX

Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company’s philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.

Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations.

Nanobiotix is the owner of more than 25 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.

For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.

Contacts

Nanobiotix
Communications Department Brandon Owens VP, Communications +1 (617) 852-4835 contact@nanobiotix.com	Investor Relations Department Joanne Choi VP, Investor Relations (US) +1 (713) 609-3150 Ricky Bhajun Director, Investor Relations (EU) +33 (0) 79 97 29 99 investors@nanobiotix.com
Media Relations
France – HARDY Caroline Hardy +33 06 70 33 49 50 carolinehardy@outlook.fr	Global – uncapped Becky Lauer +1 (646) 286-0057 uncappednanobiotix@uncappedcommunications.com

  Attachment

• 2026-02-25 -- NBTX -- Presenting @ March Conferences -- FINAL

FAQ

When will NANOBIOTIX (NBTX) present at the TD Cowen Health Care Conference?

They will present on Wednesday, March 4, 2026 at 11:10am ET. According to the company, CEO Laurent Levy and CFO Bart van Rhijn will participate in a fireside chat in Boston, providing management updates and investor outreach opportunities.

Which NANOBIOTIX (NBTX) executives will attend the March 2026 investor conferences?

CEO Laurent Levy and CFO & Business Officer Bart van Rhijn will attend multiple events. According to the company, they will lead fireside chats and investor meetings across Boston and Miami Beach in early March 2026.

What dates will NANOBIOTIX (NBTX) be at investor conferences in Miami Beach?

Nanobiotix will attend Miami Beach events on March 9, 10 and 11, 2026. According to the company, they will participate in UBS Biotech Summit, Jefferies Biotech on the Beach, and Leerink's Global Healthcare Conference.

What time is the Nanobiotix (NBTX) fireside chat at Leerink's Global Healthcare Conference?

The Leerink fireside chat is scheduled for 2:20pm EDT on March 11, 2026. According to the company, CEO Laurent Levy and CFO Bart van Rhijn will present and be available for investor questions during that session.

Will Nanobiotix (NBTX) host investor meetings at TD Cowen and Leerink in March 2026?

Yes, management will host scheduled fireside chats at both conferences. According to the company, sessions are set for March 4 in Boston and March 11 in Miami Beach, offering investor briefings and Q&A opportunities.

How can investors find Nanobiotix (NBTX) presentations during the March 2026 conferences?

Investors can attend the listed conference sessions in person on the scheduled dates and times. According to the company, specific session times are March 4 at 11:10am ET and March 11 at 2:20pm EDT for fireside chats.